327 related articles for article (PubMed ID: 19812605)
21. The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders.
Wasco MJ; Fullen D; Su L; Ma L
Hum Pathol; 2008 Apr; 39(4):557-63. PubMed ID: 18234282
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
[TBL] [Abstract][Full Text] [Related]
23. Papular mycosis fungoides: report of two patients, literature review, and conceptual re-appraisal.
Noe MH; Drake A; Link BK; Liu V
J Cutan Pathol; 2013 Aug; 40(8):714-9. PubMed ID: 23651057
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
25. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
26. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
27. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions.
Woodrow SL; Basarab T; Russell Jones R
Clin Exp Dermatol; 1996 Sep; 21(5):370-3. PubMed ID: 9136160
[TBL] [Abstract][Full Text] [Related]
28. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
29. Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas.
Salgado R; Gallardo F; Servitje O; Estrach T; García-Muret MP; Romagosa V; Florensa L; Serrano S; Salido M; Solé F; Pujol RM; Espinet B
Cancer Genet; 2011 Jul; 204(7):405-9. PubMed ID: 21872828
[TBL] [Abstract][Full Text] [Related]
30. Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity.
Nevet MJ; Zuckerman T; Sahar D; Bergman R
Am J Dermatopathol; 2015 Jan; 37(1):73-7. PubMed ID: 25548993
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis.
Karai LJ; Kadin ME; Hsi ED; Sluzevich JC; Ketterling RP; Knudson RA; Feldman AL
Am J Surg Pathol; 2013 Aug; 37(8):1173-81. PubMed ID: 23648461
[TBL] [Abstract][Full Text] [Related]
32. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
34. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
[TBL] [Abstract][Full Text] [Related]
35. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579
[TBL] [Abstract][Full Text] [Related]
36. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
[TBL] [Abstract][Full Text] [Related]
37. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
[TBL] [Abstract][Full Text] [Related]
38. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
[TBL] [Abstract][Full Text] [Related]
39. The pathology of cutaneous T-cell lymphoma.
Robson A
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):9-12. PubMed ID: 17474353
[TBL] [Abstract][Full Text] [Related]
40. The expression of CXCR3 and CD30 in mycosis fungoides.
Nikoo A
Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]